Disease

Thyroid Cancer

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · PHASE 1 TRIAL

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

ClinicalTrials.gov

Phase 1 dose escalation and expansion trial with no results posted; registry record describes planned safety and efficacy assessment in advanced solid tumors but contains no outcome data.

PreliminaryPF-07799544 Glioma PF-07799933

Reported

Estimated enrollment124

Study phasePhase 1

Primary outcome measure (Phase 1a…Number of participants with dose limiting t…

AUG 10, 2026 · PHASE 4 TRIAL

Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

ClinicalTrials.gov

This is a Phase 4 interventional study registration with no results posted; it describes planned pharmacokinetic endpoints in a small estimated cohort and cannot support clinical efficacy or safety conclusions.

PreliminaryPralsetinib NCT07704658 Solid Tumor Malignancies

Reported

Estimated enrollment12

Primary outcome measure 1Area Under the Plasma Concentration-Time Cu…

Primary outcome measure 2Area under the plasma concentration-time cu…